Tsimberidou AM - Search Results

1

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, Keating MJ. Tsimberidou AM, et al. J Clin Oncol. 2006 May 20;24(15):2343-51. doi: 10.1200/JCO.2005.05.0187. J Clin Oncol. 2006. PMID: 16710033

2

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.

Tsimberidou AM, Murray JL, O'Brien S, Wierda WG, Keating MJ. Tsimberidou AM, et al. Cancer. 2004 May 15;100(10):2195-200. doi: 10.1002/cncr.20252. Cancer. 2004. PMID: 15139064 Free article.

3

Richter syndrome: biology, incidence, and therapeutic strategies.

Tsimberidou AM, Keating MJ. Tsimberidou AM, et al. Cancer. 2005 Jan 15;103(2):216-28. doi: 10.1002/cncr.20773. Cancer. 2005. PMID: 15578683 Free article. Review.

4

Richter's transformation in chronic lymphocytic leukemia.

Tsimberidou AM, Keating MJ. Tsimberidou AM, et al. Semin Oncol. 2006 Apr;33(2):250-6. doi: 10.1053/j.seminoncol.2006.01.016. Semin Oncol. 2006. PMID: 16616072 Review.

5

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

Tsimberidou AM, O'Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, Lerner S, Bueso-Ramos CE, Keating MJ. Tsimberidou AM, et al. Cancer. 2006 Sep 15;107(6):1294-302. doi: 10.1002/cncr.22121. Cancer. 2006. PMID: 16902984 Free article.

6

The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients.

Tsimberidou AM, Kantarjian HM, Wen S, O'Brien S, Cortes J, Wierda WG, Koller C, Pierce S, Brandt M, Freireich EJ, Keating MJ, Estey EH. Tsimberidou AM, et al. Clin Cancer Res. 2008 Feb 1;14(3):721-30. doi: 10.1158/1078-0432.CCR-07-2063. Clin Cancer Res. 2008. PMID: 18245532

7

Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, Pierce S, Freireich EJ, Medeiros LJ, Estey E. Tsimberidou AM, et al. Cancer. 2008 Sep 15;113(6):1370-8. doi: 10.1002/cncr.23691. Cancer. 2008. PMID: 18623376 Free PMC article. Clinical Trial.

8

Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ. Tsimberidou AM, et al. J Clin Oncol. 2009 Feb 20;27(6):904-10. doi: 10.1200/JCO.2008.17.5398. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114699 Free PMC article.

9

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia.

Tsimberidou AM, Tam C, Abruzzo LV, O'Brien S, Wierda WG, Lerner S, Kantarjian HM, Keating MJ. Tsimberidou AM, et al. Cancer. 2009 Jan 15;115(2):373-80. doi: 10.1002/cncr.23993. Cancer. 2009. PMID: 19117034 Free PMC article.

10

Treatment of fludarabine-refractory chronic lymphocytic leukemia.

Tsimberidou AM, Keating MJ. Tsimberidou AM, et al. Cancer. 2009 Jul 1;115(13):2824-36. doi: 10.1002/cncr.24329. Cancer. 2009. PMID: 19402170 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters